Julia Lewis is a Consultant Addiction Psychiatrist with the Aneurin Bevan University Health Board, Caerleon and Visiting Professor at the University of South Wales, both in the UK. She has worked in the field of opiate addiction for over 15 years and was a member of the working group responsible for the most recent update to ‘Drug misuse and dependence: UK guidelines on clinical management.’ She is a member of the Substance Misuse National Partnership Board for Wales and has worked on a number of the substance misuse national treatment frameworks for Wales. She was a member of the working group that introduced the national take-home naloxone programme in Wales and, during the recent pandemic, she worked alongside colleagues in local drug treatment services and Welsh Government to roll out injectable buprenorphine (and is now involved in the national evaluation programme). Disclosure: Professor Julia Lewis has a consultancy agreement in place with Camurus to engage in educational activities for which she receives honoraria.

Catriona Matheson has a variety of roles including part-time Professor in Substance Use at the University of Stirling, Chair of the Drug Death Taskforce for Scotland, Co-convenor of the Drugs Research Network Scotland (DRNS), and freelance Research Consultant. Her research interests, spanning over 25 years, are in the delivery of care to people who use drugs. She completed a BSc in pharmacy at the University of Strathclyde and both an MSc in public health and PhD in Medical Sciences at the University of Aberdeen, UK. Professor Matheson was made a Fellow of the Royal Pharmaceutical Society in 2019 for her work in the field of drug dependence. With over 70 publications, past research included developing delivery of care for people who use drugs and exploring health professionals’ and the general public’s opinions about drug treatment approaches. Current interests include innovative community pharmacy services and using digital solutions to prevent drug-related deaths. Disclosures: Professor Catriona Matheson has received payment/honoraria from Camurus, UK Government, Scottish Government, Drugs Research Network for Scotland and the Scottish Drugs Forum.

Jan Melichar, has been an NHS Consultant Lead for Opiate Prescribing Services and the Inpatient Substance Misuse Liaison Services in Cardiff, UK. He is also a Visiting Senior Lecturer in Psychopharmacology at the University of Bath and a Visiting Professor at the University of South Wales, UK. Alongside this, he continues to provide consultancy work to industry and commissioners. He has been Medical Director of a third sector NHS provider, Consultant Lead for a Primary Care Opioid Analgesic Dependency Pilot Service, Research Director for a Clinical Research Organisation and Medical Director and Founder of a medical device start-up. He has previously been Lead Consultant in a regional NHS Psychopharmacology Unit, working with patients with difficult-to-treat anxiety and depression. In 2015, he was elected a Fellow of the Royal College of Psychiatrists, and he was re-elected to the National Executive, Addictions Faculty, of the College in 2018. Disclosures: Professor Jan Melichar has provided consultancy work, presentations, and training, for Althea (UK), Accord (Europe), Britannia (UK), Camurus (UK, Europe and Global), Martindale (UK), Indivior (Global, UK, EMEA and Australian divisions) and US World Meds (US).

Nat Wright has almost 25 years’ experience as a clinical academic exploring the health needs of vulnerable groups including wider health and social care needs pertaining to substance misuse, homelessness and wider health inequalities. He is also the Primary Care Specialty Lead, for the UK National Institute for Health Research, Yorkshire and Humber region and has a wealth of experience pertaining to the appropriate use of routinely collected clinical datasets for research purposes. He also leads the UK Royal College of General Practitioners courses in substance and alcohol misuse. Over the last 20 years, almost 30,000 individuals have completed such courses and Dr Wright has contributed to course development since inception. Disclosures: Dr Nat Wright has received a research grant from Camurus and a training grant from Accord.